Why don't beta blockers kill you

"Allergy can kill - anaphylaxis"


1. Worm, M. et al., Triggers and Therapy of Anaphylaxis. Dtsch Arztebl Int. 2014. 111 (21): 367-376.
2. McNeil, BD. et al., Identification of a mast-cell specific receptor crucial for pseudo-allergic drug reactions. Nature. 2015. 519 (7542): 237-41.
3. Grabenhenrich, LB. et al., Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016. pii: S0091-6749 (15) 02991-7.
4. Worm, M. et al., First European data from the network of severe allergic reactions (NORA). Allergy. 2014. 69 (10): 1397-404.
5. Turner, PJ. et al., Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Pract. 2017. 5 (5): 1169-1178.
6. © Federal Statistical Office (Destatis)
7. Sampson, HA. et al., Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease / Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006. 47 (4): 373-80.
8. Ring, J. et al., Guideline on Acute Therapy and Management of Anaphylaxis. Allergo J Int. 2014. 23:96.
9. Beyer, K. et al., Anaphylaxis in an emergency setting - elicitors, therapy and incidence of severe allergic reactions. Allergy. 2012. 67 (11): 1451-6.
10. Worm, M. et al., Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry. Allergy. 2018.
11. Worm, M. et al., Triggers and Risk Factors of Anaphylaxis. J Dtsch Dermatol Ges. 2013. 11: 44-50.
12. Nassiri, M. et al., Serum levels of 9α, 11β-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis. J Allergy Clin Immunol. 2016. 137 (1): 312-4.